** Shares of GSK GSK.L up 4.5% at 1,442p - top pct gainer on the FTSE 100 index .FTSE
** The British drugmaker lifts 2031 sales target to more than 40 bln pounds from the 38 bln pounds previously expected
** Co beats Q4 earnings with core EPS of 23.2p vs IBES ests of 19.01p, on strength in its HIV and oncology portfolio
** Reports Q4 sales of 8.12 bln pounds ($10.15 bln), above IBES ests of 7.75 bln pounds
** Launches share buyback of 2 bln pounds
** Sets 2025 sales growth target of 3%-5% against analysts' expectations for growth of about 3.5%, according to a company-compiled consensus
** GSK fell about 12% in the last 12 months
($1 = 0.8002 pounds)
(Reporting by Yamini Kalia in Bengaluru)
((Yamini.Kalia@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。